期刊
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
卷 52, 期 11, 页码 -出版社
WILEY
DOI: 10.1111/eci.13853
关键词
COVID-19; molecular diagnostic assays; nucleic acid amplification techniques; point-of-care testing; SARS-CoV-2
资金
- National Institute for Genetic Engineering and Biotechnology [99/1443]
- University of Isfahan
Background diagnosis is an important strategy to tackle infectious diseases like COVID-19. New isothermal-based methods are being developed to overcome limitations of current methods and provide affordable and easy-to-use diagnostic platforms. Point-of-care testing development can aid in clinical decision-making and alleviate burdens on healthcare facilities.
Background Diagnosis is one of the main strategies to deal with infectious and deadly diseases such as coronavirus disease 2019 (COVID-19). The global pandemic of COVID-19 has led to an immediate need to expand rapid diagnostic techniques. New isothermal-based methods are being developed for COVID-19 detection aiming to resolve the limitations related to the reverse transcription-quantitative polymerase chain reaction (RT-qPCR) method through immediate samples processing and minimizing false-negative or ambiguous results. Advances in nucleic acid amplification techniques (NAATs) can provide affordable and easy-to-use diagnostic platforms with high sensitivity and specificity in order to be available to the public as approved commercial kits. Aims The development of point-of-care (POC) testing can assist in rapid clinical decision-making and mitigate burdens on health care facilities. Finally, we discussed the different diagnostic methods based on NAATs for COVID-19 in detail. Comparative parameters are addressed for all assays and Emergency Use Authorizations (EUA)-approved commercial tests are cited. Conclusions Isothermal-coupled methods and LAMP-based molecular methods have been suggested as suitable portable tests with high diagnostic speed for use in POC testing.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据